Lattice_grid_med
Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term mutation. Found 28 abstracts

paginate
Friebel TM, Andrulis IL, Balmana J, Blanco AM, Couch FJ, Daly MB, Domchek SM, Easton DF, Foulkes WD, Ganz PA, Garber J, Glendon G, Greene MH, Hulick PJ, Isaacs C, Jankowitz RC, Karlan BY, Kirk J, Kwong A, Lee A, Lesueur F, Lu KH, Nathanson KL, Neuhausen SL, Offit K, Palmero EI, Sharma P, Tischkowitz M, Toland AE, Tung N, van Rensburg EJ, Vega A, Weitzel JN, Hoskins KF, Maga T, Parsons MT, McGuffog L, Antoniou AC, Chenevix-Trench G, Huo D, Olopade OI, Rebbeck TR. BRCA1 and BRCA2 Pathogenic Sequence Variants in Women of African Origin or Ancestry. Hum Mutat. 2019 Oct;40(10):1781-96.   PMCID: PMC6764847
Blay JY, von Mehren M. Nilotinib: A Novel, Selective Tyrosine Kinase Inhibitor. Seminars in Oncology. 2011 Apr;38(2):S3-S9.   PMCID: not NIH funded
Maxwell CA, Benitez J, Gomez-Baldo L, Osorio A, Bonifaci N, Fernandez-Ramires R, Costes SV, Guino E, Chen H, Evans GJ, Mohan P, Catala I, Petit A, Aguilar H, Villanueva A, Aytes A, Serra-Musach J, Rennert G, Lejbkowicz F, Peterlongo P, Manoukian S, Peissel B, Ripamonti CB, Bonanni B, Viel A, Allavena A, Bernard L, Radice P, Friedman E, Kaufman B, Laitman Y, Dubrovsky M, Milgrom R, Jakubowska A, Cybulski C, Gorski B, Jaworska K, Durda K, Sukiennicki G, Lubinski J, Shugart YY, Domchek SM, Letrero R, Weber BL, Hogervorst FB, Rookus MA, Collee JM, Devilee P, Ligtenberg MJ, van der Luijt RB, Aalfs CM, Waisfisz Q, Wijnen J, van Roozendaal CE, Easton DF, Peock S, Cook M, Oliver C, Frost D, Harrington P, Evans DG, Lalloo F, Eeles R, Izatt L, Chu C, Eccles D, Douglas F, Brewer C, Nevanlinna H, Heikkinen T, Couch FJ, Lindor NM, Wang XS, Godwin AK, Caligo MA, Lombardi G, Loman N, Karlsson P, Ehrencrona H, von Wachenfeldt A, Barkardottir RB, Hamann U, Rashid MU, Lasa A, Caldes T, Andres R, Schmitt M, Assmann V, Stevens K, Offit K, Curado J, Tilgner H, Guigo R, Aiza G, Brunet J, Castellsague J, Martrat G, Urruticoechea A, Blanco I, Tihomirova L, Goldgar DE, Buys S, John EM, Miron A, Southey M, Daly MB, Schmutzler RK, Wappenschmidt B, Meindl A, Arnold N, Deissler H, Varon-Mateeva R, Sutter C, Niederacher D, Imyamitov E, Sinilnikova OM, Stoppa-Lyonne D, Mazoyer S, Verny-Pierre C, Castera L, de Pauw A, Bignon YJ, Uhrhammer N, Peyrat JP, Vennin P, Ferrer SF, Collonge-Rame MA, Mortemousque I, Spurdle AB, Beesley J, Chen XQ, Healey S, Barcellos-Hoff MH, Vidal M, Gruber SB, Lazaro C, Capella G, McGuffog L, Nathanson KL, Antoniou AC, Chenevix-Trench G, Fleisch MC, Moreno V, Pujana MA. Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer. Plos Biology. 2011 Nov;9(11):e1001199.   PMCID: PMC3217025
Manne SL, Meropol NJ, Weinberg DS, Vig H, Catts ZA, Manning C, Ross E, Shannon K, Chung DC. Facilitating Informed Decisions Regarding Microsatellite Instability Testing Among High-Risk Individuals Diagnosed With Colorectal Cancer. Journal of Clinical Oncology. 2010 Mar;28(8):1366-72.   PMCID: PMC2834496
Johnatty SE, Couch FJ, Fredericksen Z, Tarrell R, Spurdle AB, Beesley J, Chen XQ, Gschwantler-Kaulich D, Singer CF, Fuerhauser C, Fink-Retter A, Domchek SM, Nathanson KL, Pankratz VS, Lindor NM, Godwin AK, Caligo MA, Hopper J, Southey MC, Giles GG, Justenhoven C, Brauch H, Hamann U, Ko YD, Heikkinen T, Aaltonen K, Aittomaki K, Blomqvist C, Nevanlinna H, Hall P, Czene K, Liu JJ, Peock S, Cook M, Platte R, Evans DG, Lalloo F, Eeles R, Pichert G, Eccles D, Davidson R, Cole T, Cook J, Douglas F, Chu C, Hodgson S, Paterson J, Hogervorst FB, Rookus MA, Seynaeve C, Wijnen J, Vreeswijk M, Ligtenberg M, van der Luijt RB, van Os TA, Gille HJ, Blok MJ, Issacs C, Humphreys MK, McGuffog L, Healey S, Sinilnikova O, Antoniou AC, Easton DF, Chenevix-Trench G. No evidence that GATA3 rs570613 SNP modifies breast cancer risk. Breast Cancer Research and Treatment. 2009 Sep;117(2):371-9.   PMCID: PMC2728174
Neuhausen SL, Brummel S, Ding YC, Singer CF, Pfeiler G, Lynch HT, Nathanson KL, Rebbeck TR, Garber JE, Couch F, Weitzel J, Narod SA, Ganz PA, Daly MB, Godwin AK, Isaacs C, Olopade OI, Tomlinson G, Rubinstein WS, Tung N, Blum JL, Gillen DL. Genetic variation in insulin-like growth factor signaling genes and breast cancer risk among BRCA1 and BRCA2 carriers. Breast Cancer Research. 2009 Jan;11(5).   PMCID: PMC2790858
Tchou J, Ward MR, Volpe P, Palma MD, Medina CA, Sargen M, Sonnad SS, Godwin AK, Daly M, Winchester DJ, Garber J, Weber BL, Domchek S, Nathanson KL. Large genomic rearrangement in BRCA1 and BRCA2 and clinical characteristics of men with breast cancer in the United States. Clinical Breast Cancer. 2007 Jun;7(8):627-33.
Chen ML, Xu PZ, Peng XD, Chen WS, Guzman G, Yang XM, Di Cristofano A, Pandolfi PP, Hay N. The deficiency of Akt1 is sufficient to suppress tumor development in Pten(+/-) mice. Genes & development. 2006 Jun;20(12):1569-74.
Locker GY, Kaul K, Weinberg DS, Gatalica Z, Gong G, Peterman A, Lynch J, Klatzco L, Olopade OI, Bomzer CA, Newlin A, Keenan E, Tajuddin M, Knezetic J, Coronel S, Lynch HT. The I1307K APC polymorphism in Ashkenazi Jews with colorectal cancer: clinical and pathologic features. CANCER GENETICS AND CYTOGENETICS. 2006 Aug;169(1):33-8.
Knudson AG. A personal sixty-year tour of genetics and medicine. Annual Review of Genomics and Human Genetics. 2005 Jan;6:1-14.
Cairns P, Adams PD. Clipped wings - Epigenetic inactivation of APC. Cancer Biology & Therapy. 2004 Oct;3(10):965-6.
Hensley HH, Chang WC, Clapper ML. Detection and volume determination of colonic tumors in Min mice by magnetic resonance micro-imaging. Magnetic Resonance in Medicine. 2004 Sep;52(3):524-9.
Feng SL, Guo Y, Factor VM, Thorgeirsson SS, Bell DW, Testa JR, Peifley KA, Winkles JA. The Fn14 immediate-early response gene is induced during liver regeneration and highly expressed in both human and murine hepatocellular carcinomas. American Journal of Pathology. 2000 Apr;156(4):1253-61.
Daniel R, Katz RA, Skalka AM. A role for DNA-PK in retroviral DNA integration. Science (New York, NY). 1999 Apr 23;284(5414):644-7.
Daly M, Obrams GI. Epidemiology and risk assessment for ovarian cancer. Seminars in Oncology. 1998 Jun;25(3):255-64.
Lehman AL, Nakatsu Y, Ching A, Bronson RT, Oakey RJ, Keiper-Hrynko N, Finger JN, Durham-Pierre D, Horton DB, Newton JM, Lyon MF, Brilliant MH. A very large protein with diverse functional motifs is deficient in rjs (runty, jerky, sterile) mice. Proceedings of the National Academy of Sciences of the United States of America. 1998 Aug 04;95(16):9436-41.
Plank TL, Yeung RS, Henske EP. Hamartin, the product of the tuberous sclerosis 1 (TSC1) gene, interacts with tuberin and appears to be localized to cytoplasmic vesicles. Cancer Research. 1998 Nov;58(21):4766-70.
Malinow MR, Nieto FJ, Kruger WD, Duell PB, Hess DL, Gluckman RA, Block PC, Holzgang CR, Anderson PH, Seltzer D, Upson B, Lin QR. The effects of folic acid supplementation on plasma total homocysteine are modulated by multivitamin use and methylenetetrahydrofolate reductase genotypes. Arteriosclerosis Thrombosis and Vascular Biology. 1997 Jun;17(6):1157-62.
Xiao GH, Shoarinejad F, Jin F, Golemis EA, Yeung RS. The tuberous sclerosis 2 gene product, tuberin, functions as a Rab5 GTPase activating protein (GAP) in modulating endocytosis. Journal of Biological Chemistry. 1997 Mar 07;272(10):6097-100.
Gulati S, Baker P, Li YN, Fowler B, Kruger W, Brody LC, Banerjee R. Defects in human methionine synthase in cblG patients. Human molecular genetics. 1996 Dec;5(12):1859-65.
Jin F, Wienecke R, Xiao GH, Maize JC, DeClue JE, Yeung RS. Suppression of tumorigenicity by the wild-type tuberous sclerosis 2 (Tsc2) gene and its C-terminal region. Proceedings of the National Academy of Sciences of the United States of America. 1996 Aug 20;93(17):9154-9.
LeFur N, Kelsall SR, Mintz B. Base substitution at different alternative splice donor sites of the tyrosinase gene in murine albinism. Genomics. 1996 Oct 15;37(2):245-8.
Mitsunaga SI, Zhang SY, Ruggeri BA, Gimenezconti I, Robles AI, Conti CJ, Kleinszanto AJ. Positive Immunohistochemical Staining of P53 and Cyclin-D in Advanced Mouse Skin Tumors, but Not in Precancerous Lesions Produced by Benzo a Pyrene. Carcinogenesis. 1995 Jul;16(7):1629-35.
Rebbeck TR, Lustbader ED, Buetow KH. Somatic Allele Loss in Genetic-Linkage Analysis of Cancer. Genetic epidemiology. 1994 Jan;11(5):419-29.
Safrany G, Perry RP. Transcription factor RFX1 helps control the promoter of the mouse ribosomal protein-encoding gene rpL30 by binding to its ? element. Gene. 1993 Jan;132(2):279-83.
Brilliant MH, Gondo Y. Molecular Characterization of the P(Un) Allele of the Mouse Pink-Eyed Dilution Locus. Pigment Cell Research. 1992 Nov;5(5):271-3.
Roth DB, Menetski JP, Nakajima PB, Bosma MJ, Gellert M. V(D)J Recombination - Broken DNA-Molecules with Covalently Sealed (Hairpin) Coding Ends in Scid Mouse Thymocytes. Cell. 1992 Sep 18;70(6):983-91.
Brilliant MH, Gondo Y, Eicher EM. Direct molecular identification of the mouse pink-eyed unstable mutation by genome scanning. Science (New York, NY). 1991 Jan;252(5005):566-9.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term mutation

mutation dominantly inherited cancer growth identification model carriers expression pathway mice susceptibility tsc2 gene protein cancer mammary-gland gene retinoblastoma eker rat model carcinogenesis eker rat mouse Genetics & Heredity heterozygosity chromosome in-vivo recombination tumors regulatory promoter element heterogeneity mouse tyrosinase two hits cancer-genetic chaos estrogen receptor hereditary RISK ligase-iv mri imatinib-resistant pkb vitamin therapy reducing morbidity cells pathogenic sequence variant multiple intestinal neoplasia phenotypic characteristics rearrangement delta-genes factor-i gene family combined immune-deficiency chronic myelogenous leukemia avian-sarcoma Promoter Regions (Genetics) ashkenazi jewish mutation Brca2 somatic genetic mutation brca1-dependent ubiquitination multiethnic cohort APC breast-cancer luminal cell fate transcripts risk African Ancestry growth-factor-alpha binding protein-5 igfbp-5 strand break repair glutamyl-transferase transpeptidase single-nucleotide polymorphism akt DELETIONS antigen receptor genes transgenic mice hepatectomy GERMLINE MUTATIONS POPULATION genetic reversion united-states common amn107 nilotinib papillomas missense mutations dna binding gene mutations fusion white women brain Brca1 CARRIERS cancer therapy eumelanin density supercoiled dna prostate cancers Genes deletion c-myc talc locus p-locus Mutation ovarian-cancer transcription regulation mouse genetics Oncology familial breast repair promoter region membrane- Developmental Biology estrogen-receptor association attitudes mitotic spindle centrosomal microtubule nucleation mammographic gastrointestinal stromal tumors phosphoinositide 3-kinase chromosome 9q34 mouse mutations clinicopathological features wingless MHC class-II gene prostate-cancer angelman-syndrome giant-cell tumor Wnt colon-cancer mortality lod score suppressor adherens junctions c-kit gamma-glutamyltransferase 2002 eeseman im-cell-v111-p163 genetically-engineered mice carcinomas magnetic resonance imaging mice-planimetry-multiple intestinal neoplasia-colon inducible expression rcc1 FAMILIES women loss of heterozygosity site-specific recombination therapeutic target tissues dependent dna polymerase deficiency SUSCEPTIBILITY GENE binding cdna dna-sequences
Last updated on Friday, December 06, 2019